Novel risk profiling technologies to guide adjuvant chemotherapy decisions in early breast cancer

Status:

Awaiting development

Technology type:

Device

Decision:

Selected

Prioritisation programme:

HealthTech

Rationale:

Tumour profiling technologies are used to assess the risk of recurrence in breast cancer patients after surgery. A risk score or category is estimated, and this is used as a decision aid when determining if the patient should receive adjuvant chemotherapy. 

Timeline

Key events during the development of the guidance:

For further information on our processes and methods, please see our CHTE processes and methods manual